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Abstract
Background: Prostate cancer is the most common cancer diagnosed among adult males in the
United States. The prognosis of prostate cancer is related to the stage, with a five year relative
survival rate of 100% among men diagnosed with early stage prostate cancer. Modifiable risk
factors associated with the disease include lifestyle, marital status, tobacco and alcohol history,
physical activity, weight, diet, and geographic location. Non-modifiable risk factors include
family history and genetic factors, race/ethnicity and nationality, age, and hormonal factors.
Methods: A descriptive study of prostate cancer primary prevention and early detection factors
was conducted on men living in Montgomery County, Ohio utilizing data from Ohio Cancer
Incidence and Surveillance System, and secondary data sources. Additionally, a descriptive
analysis was conducted on men diagnosed with prostate cancer living in Montgomery County.
Results: Montgomery County had the third highest prostate cancer incidence and mortality
compared to Ohio, the US, and other counties with comparable population sizes and
demographics. Additionally, a large percentage of men were diagnosed with early stage prostate
cancer. Eighty three percent of men living in the county diagnosed with the disease survived.
Discussion: Men living in Montgomery County are likely to be diagnosed with early stage
prostate cancer. The county had a low prostate cancer mortality rate which may be associated
with factors such as early stage diagnosis. Measures can be taken to decrease prostate cancer
health disparities through community-based participatory education, training, and research
among racial/ethnic minorities and underserved populations in Montgomery County.

Keywords: Prostate Cancer, Incidence, Risk Factors, Stage at Diagnosis, Symptoms, Treatment
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Montgomery County Prostate Cancer Study
A Descriptive Study of Prostate Cancer Incidence & Mortality in Montgomery County, Ohio,
2000-2009
Cancer is a major public health issue in the United States (US) (Centers for Disease
Control and Prevention, 2011). It is the leading cause of global mortality, accounting for nearly
eight million deaths in 2008, and is expected to rise to eleven and a half million deaths by the
year 2030 (World Health Organization, 2012).
Prostate cancer is the most common cancer, other than non-melanoma skin cancer,
diagnosed among males of all ages, and the second leading cause of cancer-related death among
men in the US (National Institutes of Health, 2011). The causes of prostate cancer remain
unknown; however there are multiple known risk factors that contribute to men developing the
disease. A risk factor is a variable associated with an increased risk of disease or infection. There
are both modifiable and non-modifiable risk factors for prostate cancer. Modifiable risk factors
include lifestyle, marital status, tobacco and alcohol history, physical activity, obesity, and diet.
Non-modifiable risk factors include genetic factors, family history, race/ethnicity and nationality,
age, and hormonal factors (U.S. National Library of Medicine, 2010).
The purpose of this descriptive study is to examine the trend in mortality and incidence of
prostate cancer among the male population of Montgomery County, Ohio from 2000 to 2009
using available data sets and secondary data sources. Additionally, this study aims to address the
various risk factors associated with prostate cancer. Lastly, a goal of this study is to describe
some demographic related variables such as marital status, city, race, sex, age of diagnosis, and
primary payer to determine if an association exists between these variables and prostate cancer in
Montgomery County. This study aims to assist Public Health – Dayton & Montgomery County
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with health promotion/preventative programs. Additionally, this study is likely to yield
generalizable knowledge to further clinicians' understanding of prostate cancer.
Literature Review
Cancer, known medically as a malignant neoplasm, is a broad group of various diseases
caused by abnormal cell proliferation. When cells in a part of the body divide uncontrollably, the
resulting excess of tissue that develops is called a tumor or neoplasm (World Health
Organization, 2012). Tumors may be cancerous and terminal or they may be harmless.
Cancerous tumors are referred to as malignant tumors with the ability to spread to adjoining parts
of the body through the lymphatic system or the blood stream; this is referred to as metastasis,
which is the major cause of death from cancer. A harmless tumor is a neoplasm that does not
metastasize (World Health Organization, 2012).
Multiple factors may prompt a normal functioning cell to lose control and become
cancerous. However, determining a single cause of cancer is difficult. There are multiple risk
factors for cancer such as tobacco use, alcohol abuse, infections from viruses or bacteria,
physical inactivity, poor diet, obesity, ultraviolet and ionizing radiation, and environmental
agents such as the air we breathe, drinking water, and some foods we consume (World Health
Organization, 2012). These risk factors can damage genes or unite with genetic abnormalities
within cells leading to cancer (Kinzler & Vogelstein, 2002).
Cancer can be detected through the presence of specific signs and symptoms, cancer
screening tests, or medical imaging examinations. If a specific form of cancer is detected, it is
diagnosed by a histopathological examination of a biopsy (Jemal et al., 2011). Most types of
cancer are surgically removed. However, when a cancerous tumor metastasizes to multiple parts
of the body or exists discretely in organs such as the prostate, other treatments such as
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medication, radiation therapy, hormone therapy, chemotherapy, cryosurgery, or heat intensity
focused ultrasound treatment of the prostate are used singly or in combination to treat the disease
(Mayo Clinic, 2012).
Prostate cancer was initially identified in 1853 by British surgeon James Adams, MD.
Initially, Dr. Adams noted prostate cancer as an uncommon disease. Remarkably, almost two
centuries later, prostate cancer has become a major public health problem (Denmeade & Isaacs,
2002). It tends to develop slowly; however, it can develop aggressively and metastasize to other
regions of the body such as the lymph nodes and bones. Given the slow development, many men
typically pass away unaware that they had the disease. Early cases of prostate cancer tend to be
asymptomatic, but some early signs may be frequent urination, difficulty initiating urination,
blood in the urine, and weak or painful urination (American Cancer Society, 2011).
The incidence rate of prostate cancer is significantly higher for African American men
compared to Caucasian men; the incidence of prostate cancer in African American men is
approximately thirty to fifty percent higher than their Caucasian counterpart of a similar age
(Reddy, Shapiro, & Brawley, 2003). Additionally, African American men mortality rate from
prostate cancer is two times greater than Caucasian men. The time period from diagnosis to death
is highly dependent upon the stage and age of diagnosis, with the time period spanning longer for
Caucasian men than African American men (Reddy, Shapiro, & Brawley, 2003).
Greek and Italian men have lower risk in comparison to African American and Caucasian
men; however, their risk of developing the disease tends to increase as they become acculturated
to American style diets with a focus on saturated fats and red meat. Japanese and Chinese men
have typically had the lowest risk of developing prostate cancer in comparison to other
ethnicities. However, their incidence rates have been increasing within the last few years; this
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increase has been attributed to the rising levels of obesity throughout the country (Hsing &
Chokkalingam, 2006).
The Prostate Gland
The prostate gland was initially described by Niccolò Massa, a Venetian anatomist, in
1536, and Andreas Vesalius, a Flemish anatomist, in 1538 (Denmeade & Isaacs, 2002). It is an
exocrine gland that is part of the male reproductive system. It is a small muscular rounded organ
about the size of a walnut. It is inferior to the urinary bladder and anterior to the rectum (Prostate
Cancer Treatment Guide, 2010). It surrounds the upper portion of the urethra, the duct which
expels urine from the body. The lower portion of the prostate is linked to the urinary sphincter,
which is responsible for the control of urine flow (Prostate Cancer Foundation, 2011).
The prostate gland is a fundamental part of the male reproductive system; however, it is
not essential for life. It secretes a milky acidic fluid (pH of about 6.5) called prostatic fluid,
which accounts for an estimated twenty-five percent of the volume of semen that nourishes and
carries sperm. The fluid contains seminal-plasmin, an antibiotic which may possibly assist in the
prevention of urinary tract infections (Prostate Cancer Foundation, 2011). Additionally, the cells
of the prostate gland produce prostate specific antigen (PSA), a protein normally found in males
with healthy prostates; however, higher levels are found in the presence of prostate cancer
(American Cancer Society, 2011).
The prostate gland is divided into two tissue types: glandular and non-glandular.
Glandular tissue consists of glands and ducts that produce fluid and non-glandular tissue consists
of fibromuscular tissue. The prostate gland is categorized according to a prostatic capsule that
encloses the prostate gland and four zones: the anterior fibromuscular zone, the central zone, the
transition zone, and the peripheral zone (Prostate Cancer Treatment Guide, 2010).
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The anterior fibromuscular zone accounts for an estimated five percent of the prostate
gland, but usually lacks any glandular components. The transition zone surrounds the upper
portion of the urethra and accounts for five percent of the prostate gland. An estimated fifteen
percent of prostate cancer cases originate in this zone (Urology Match, 2009). This zone tends to
enlarge beyond the age of forty, which leads to difficulty urinating because of its close proximity
to the urethra (Prostate Cancer Treatment Guide, 2010). The central zone surrounds the transition
zone and accounts for an estimated twenty-five percent of the prostate gland (Prostate Cancer
Treatment Guide, 2010). This zone accounts for three percent of prostate cancer cases that tend
to metastasize to other regions of the male reproductive system. Lastly, the peripheral zone
surrounds the lower portion of the urethra and makes up seventy percent of the prostate gland in
young men. This zone is the primary site of about seventy to eighty percent of prostate cancer
(Urology Match, 2009).
Etiology of Prostate Cancer
Prostate cancer is the most common cancer among men in the western hemisphere and
the second leading cause of death among men in the US (Hsing & Chokkalingam, 2006). Many
studies have shown that approximately eighty percent of men eighty years and older were
unaware they had the cancer prior to passing away. Thirty percent of men in their fifties and
eighty percent of men in their eighties from various geographic areas who passed away from
various causes of death were found to have prostate cancer during autopsy (American Cancer
Society, 2011).
The antecedent to prostate cancer is known as prostatic intraepithelial neoplasia (PIN)
which is defined as alterations involving the glands and ducts of the prostate. There are three
grades of PIN. Low grade PIN entails abnormal growth with abnormal cell replication,
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dissimilarity in size and shape of the nucleus, and asymmetrical cell spacing. High grades refers
to PIN grades 2 and 3, which entails moderate to severe cell replication, and irregular cell
spacing. Individuals found to have high grade PIN are at a significantly greater risk of
developing prostate cancer (Wang et al., 2011).
Prostate cancer develops within the gland cells of the prostate. The gland cells play a part
in developing the prostatic fluid found in semen. The cancer normally starts with small changes
in the shape and size of the prostate gland cells (American Cancer Society, 2011). Despite the
changes that occur in the gland cells of the prostate, there are multiple types of prostatic
carcinomas that affect the different zones of the prostate. These types of prostatic carcinomas
include: prostatic adenocarcinoma, small cell carcinoma, squamous cell carcinoma, and
transitional cell carcinoma (Wagner, Huang, & Cheng, 2012).
Prostatic adenocarcinoma tends to arise in the peripheral zone, the main glandular zone of
the prostate, and is the most common type of prostate cancer diagnosed. It accounts for an
estimated eighty to ninety percent of prostate cancer cases. Adenocarcinoma refers to a
cancerous growth that begins in epithelial cells with glandular properties. Epithelial cells play a
role in protecting or enclosing organs and removing foreign substances; some produce mucus
and other secretions. Prostatic adenocarcinoma refers to a malignant growth that originates in the
glandular tissue of the prostate gland (Prostate Cancer Treatment Guide, 2010).
Small cell carcinoma (SCCA) is an uncommon type of prostate cancer that also originates
in the peripheral zone and accounts for less than one percent of prostate carcinomas (Furtado,
Lima, Nogueira, Franco, & Tavora, 2011). Some cases of SCCA of the prostate are mixed with
prostatic adenocarcinoma (Wagner, Huang, & Cheng, 2012). This type of prostate cancer is very
aggressive and difficult to detect because it does not lead to an enhanced level of PSA. As a
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result this type of cancer tends to be detected when it has reached an advanced level (Epstein,
2008). Squamous cell carcinoma (SCC) of the prostate is a non-glandular cancer that affects the
anterior fibromuscular zone of the prostate. It accounts for approximately one percent of all
prostate carcinomas. Similar to SCCA, this form of prostate cancer is difficult to detect because
PSA levels do not increase when the cancer is present (Malik et al., 2011).
Lastly, prostatic transitional cell carcinoma (TCC) is an extremely rare form of prostate
cancer that is involved in the urethral region of the prostate and accounts for less than one
percent of prostate cancer cases. Primary prostatic TCC involves the entire region of the prostatic
urethra, while secondary prostatic TCC involves the neck of the bladder or the tissues of the
posterior portion of the prostate (Shen & Cheng, 2012).
While there are various types of prostatic carcinomas, their etiology remains ambiguous
(Wang et al., 2011). However, the vast majority of cases are related to prostatic adenocarcinoma,
which is the most wide spread form of the disease (Prostate Cancer Treatment Guide, 2010).
Despite the ambiguous etiology of prostate cancer, there are both modifiable and nonmodifiable risk factors associated with the development of the disease. Understanding of these
risk factors can enhance the knowledge of the disease and increase the survival rate by diagnosis,
in turn reducing the current mortality and incidence trends of the disease.
Modifiable Risk Factors
Lifestyle
Diets high in fats are linked to increased risk of prostate cancer due to increased
production of androgens and estrogen throughout the body (Hsing & Chokkalingam, 2006).
Consumption of red meat and processed meat has been consistently linked to prostate cancer.
Dietary calcium from dairy or supplemental products has also been linked to prostate cancer.
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Due to the role calcium has in the regulation of the synthesis of vitamin D, it may potentially
down regulate the anti-proliferative effect vitamin D has on prostate cancer (Hsing &
Chokkalingam, 2006).
Obesity has been more consistently linked with the development of prostate tumors and
abdominal obesity may be related to the development of prostate cancer. Although the role
obesity has on prostate cancer is unclear it is linked to many risk factors of prostate cancer. This
includes the high consumption of meat and fatty foods, hormone metabolism, as well as insulin
metabolism. The obesity prevalence throughout the US population is strongly correlated with the
risk of developing prostate cancer (Freedland, 2005). Lastly, research has shown that married
males have a higher survival rate from prostate cancer than unmarried men (Abdollah et al.,
2011).
Marital Status
There is a positive association between married men and prostate cancer survival rate
(Abdollah et al., 2011). In a North American population based cohort study, it was found that
married men with prostate cancer had a significantly higher survival rate compared to divorced,
separated, or widowed men. Several prostate cancer investigations have shown that married men
have a lower mortality rate than their unmarried counterparts. In a study of 30,000 married and
single men, there was a negative survival trend for single men diagnosed with prostate cancer
compared to their counterparts. Additionally, other studies have shown marriage to be a positive
predictor of men seeking treatment compared to single or widowed men (Abdollah et al., 2011).
In a recent study, 163,697 benign prostate cancer patients were treated with radical
prostatectomy. Cox regression analysis, a statistical method used for investigating the association
between the survival of a patient and multiple variables, was used to determine if there was a
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relationship between marital status and prostate cancer. The finding demonstrated that single,
divorced, and/or widowed men were more likely to have the aggressive form of prostate cancer
at radical prostatectomy compared to married men (Abdollah et al., 2011).
Additionally, research studies have shown that single, widowed, and divorced men were
more likely to abuse tobacco and alcohol (Abdollah et al., 2011). Men under the age of sixty five
who smoke a daily pack of cigarettes increase their risk of developing an aggressive type of
prostate cancer compared to nonsmokers (Stein & Colditz, 2004).
Tobacco History
A history of tobacco use is a major cause of preventable deaths globally, accounting for
an estimated five million deaths annually. In the US, adult smokers lose an estimated thirteen
years of potential life due to the negative effects associated with smoking. Additionally, it is
estimated that fifty percent of all smokers pass away from tobacco-related diseases (Stein &
Colditz, 2004). Tobacco use contributes to approximately thirty percent of all forms of cancer in
the US. Increasing evidence suggests that smoking is related to an elevated risk of prostate
cancer; however the link between cigarette smoking and prostate cancer has not been supported
by most observational studies. There are multiple ways in which cigarette smoking might
adversely promote the development and progression of prostate cancer (Watters, Park, Hollen,
Schatzkin, & Albanes, 2009). However, the risk of developing prostate cancer from tobacco use
is not limited to cigarette smoking; the risk increases with smokeless tobacco, cigar use, and pipe
smoking (Stein & Colditz, 2004).
Tobacco use negatively influences some sex hormones such that men who smoke have
elevated levels of testosterone and lower levels of estradiol, which can lead to a more aggressive,
hormone sensitive cancer consequently increasing prostate cancer mortality. Additionally,

MONTGOMERY COUNTY PROSTATE CANCER

15

smokers are also exposed to a wide variety of carcinogens such as cadmium, which can
negatively affect prostate tumor growth (Watters et al., 2009). The proliferative and carcinogenic
effects cadmium has on prostate cancer have been illustrated in vitro and in vivo. In a 2002
study, evidence supporting the effects of cadmium on prostate cancer were demonstrated when
human prostate cancer cells were exposed to cadmium. The results were a 2.4 fold increase in
cell division within one week and a 2.7 fold increase within two weeks (Martin et al., 2002).
Lastly, a study conducted on smokers and drinking behavior found that social smoking
increased the risk of alcohol abuse. Social smokers were less likely to drink daily than smokers;
however they were more likely to exceed the daily and weekly drinking quantity suggested by
the National Institute on Alcohol Abuse and Alcoholism (NIAAA) (Harrison, Desai, & McKee,
2008).
Alcohol History
A history of alcohol abuse is responsible for about two million deaths annually. Alcohol
is a carcinogen that may perhaps increase cancer risk by operating as a solvent thus allowing
carcinogens to infiltrate the mucus secreting membrane lining of the body cavity, or as an irritant
resulting in increased cell death, or perhaps as a transporter carrying carcinogens to the basal
layer of the membrane lining the body cavity (Stein & Colditz, 2004). Men who consume
alcohol heavily on a normal basis are likely putting themselves at risk for developing prostate
cancer.
A study conducted at the University of California on the association between alcohol
abuse and the risk of developing prostate cancer found that men who drank heavily diminished
the possible preventive properties of finasteride, a drug used to reduce the risk of prostate cancer
in some men. The study focused on the alcohol drinking and consumption patterns of 10,920

MONTGOMERY COUNTY PROSTATE CANCER

16

males, who were enrolled in the Prostate Cancer Prevention Trial (PCPT). The PCPT is a
National Cancer Institute study examining the possible benefits of finasteride. The findings from
the study suggested those men who drank at least fifty grams or more of alcohol daily increased
their risk of developing an aggressive form of prostate cancer. Men who drank heavily on a daily
basis were at a significantly higher risk of developing high-grade prostate cancer (Gong et al.,
2009). Another study researching the relationship between alcohol intake, body fat, and physical
activity found that alcoholics are less physically active than non alcoholics (Liangpunsakul,
Crabb, & Qi, 2010).
Physical Activity
Throughout the US adults in general do not get the recommended level of physical
activity needed to maintain a healthy lifestyle. The recommended level of physical activity is 150
minutes of weekly moderate intensity activity (Centers for Disease Control and Prevention,
2010). Physical activity is a preventative measure against the development of various chronic
diseases (Touvier et al., 2010). There is a positive relationship between the prevention of chronic
diseases and physical activity. There is strong evidence that daily physical activity contributes to
both primary and secondary prevention of numerous chronic diseases and is related to a lower
risk of early death (Darren, Warburton, Nicol, & Shannon, 2006).
According to the Behavioral Risk Factor Surveillance System (BRFSS) data from 2008,
only 64.5% of adults age 18 to 65 met the recommended levels of physical activity. Twentyseven percent of adult males were more likely to meet the recommended levels of physical
activity compared to 25.5% of women. Among ethnic groups, 56.5% of African American adults
and 50% of Hispanics were likely to meet the recommended levels of physical activity, while
72.1% of Caucasian Americans met the recommended levels (Brownson, Boehmer, & Luke,
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2005). Globally, physical inactivity causes an estimated two million deaths annually (Stein &
Colditz, 2004). Additionally, lack of physical activity may be associated with the risk of
developing prostate cancer, especially in African American men (Moore et al., 2009).
Research studies are inconsistent concerning the effects physical activity has on prostate
cancer. While it is feasible that physically active men experience a lower risk of prostate cancer,
the organic mechanisms that explain this relationship are not clear, but may be related to
alterations in energy balance, hormones, immunity, insulin-like growth factors (IGFs), and
antioxidant defense mechanisms (National Institutes of Health, 2009b). In a prospective study of
physical activity and prostate cancer, it was suggested that regular vigorous activity could slow
the development of prostate cancer in men age sixty-five and older (Giovannucci, Leitzmann,
Stampfer, & Willett, 2005).
Particularly among African American men, the association between physical activity and
prostate cancer has not been thoroughly examined. A cohort study conducted examining the
intensity of physical activity among African American and Caucasian men during different age
periods in relation to prostate cancer incidence found that physical activity may reduce prostate
cancer specifically in African Americans. The study included a total of 160,006 Caucasian men
and 3,671 African American men age fifty-one to seventy-two. During a seven year period 9,624
Caucasian men and 371 African American men developed prostate cancer. Among Caucasian
men there was no association between physical activity and prostate cancer. However, African
American men engaging in at least four hours of physical activity related to a thirty five percent
lower risk of developing the disease (Moore et al., 2009).
Physical inactivity in the last few years has increased because of a shift from a more
laborious to deskbound occupations. In the last few decades, there has been on average a weight
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increase in American men of twelve pounds. Lack of physical activity is one of the major factors
leading to a rising rate of obesity (Cutler, Glaeser, & Shapiro, 2004). In a 2005 study, a positive
association between body weight and developing prostate cancer was found in men with higher
body mass index or men who were obese.
Obesity
“Obesity is the excessive accumulation of body fat that causes undesirable effects on
health and reduces life expectancy” (Blair, 2008). The increase in obesity prevalence in the last
two decades is likely caused by the alterations in diet and physical inactivity (Freedland, 2005).
Obesity has been linked to the more aggressive form of prostate cancer. However, the specific
reason for this association is complex. Multiple organic rationalizations have been presented
including physical inactivity, poor diet, and changes in serum hormone concentration, such as
testosterone, estrogen, and insulin (Freedland, 2005).
Obesity has been linked with the decrease in free testosterone levels. Testosterone is
responsible for the development of male secondary sex characteristics. Furthermore, testosterone
is a key component in prostate growth. Data from retrospective studies have proposed that
testosterone exerts a differentiated effect on prostate cancer and that lower levels of testosterone
found in obese men is related to the aggressive form of prostate cancer (Freedland, 2005). A
prospective cohort study conducted at Johns Hopkins Bloomberg School of Public Health found
that obese men with lower levels of testosterone were at higher risk of developing prostate
cancer (Platz et al., 2005). Lower levels of free testosterone found in obese men predisposes
them to advanced prostate cancer, which may potential elucidate the higher mortality among
obese men from prostate cancer (Freedland, 2005).
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Multiple prospective cohort studies have confirmed that obese men have a higher risk of
developing and dying from prostate cancer. A prospective cohort study conducted by the
American Cancer Society found that a higher body mass index (BMI) was positively associated
with the risk of death from prostate cancer (Calle, Rodriguez, Thurmond-Walker, & Thun,
2003). BMI is a method used to measure a person’s weight in relation to their height and verifies
if a person is underweight, overweight, or obese. A BMI within the range of 19–24.9 is
considered normal weight, while a BMI within the range of 25–29.9 is considered overweight,
over 30–34.9 is considered obese, and 35–40 is considered morbidly obese (Wilder, 2009). The
prospective cohort study included 900,000 adult males who were cancer free in 1982. The men
were followed for sixteen years to evaluate their mortality risk from prostate cancer. It was found
that men with a BMI between 30 and 34.9 were twenty percent more likely to pass away from
prostate cancer than men with a normal weight and morbidly obese men were thirty five percent
more likely to die from prostate cancer (Calle et al., 2003).
A theory for the higher mortality rate among obese men suggests that the size of the
prostate in obese men is larger compared to normal weight men. Thus making it difficult to feel a
tumor and harder to find the cancer prior to a biopsy. Additionally, obese men have lower PSA
concentrations due to lower levels of testosterone. Due to the lower levels of testosterone, during
a PSA examination, obese men are less likely to have abnormal PSA results, leading to fewer
prostate cancers detected in the early stage of the disease (Freedland, 2005).
Reducing the risk of developing prostate cancer due to obesity can be accomplished
through dietary improvements, thus creating a balance between caloric intake and physical
activity (Stein & Colditz, 2004).
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Dietary Improvements
Studies in recent years have focused on the relationship between diet and prostate cancer.
Multiple factors have been investigated from diets rich in fruits and vegetables to diets rich in red
meat and animal fats. Eating a healthy well balanced diet rich in fruits and vegetables may
reduce the risk of developing prostate cancer (Stein & Colditz, 2004).
Diets high in sugar increase the risk of developing prostate cancer. A surplus of sugar is
stored as fat in the body, which leads to increased body fat increasing the production of
testosterone (Prostate Cancer Treatment Guide, 2010). Diets that rely on red meat as a source of
protein, rich in animal fats, or contain high levels of simple sugars, are positively correlated with
prostate cancer. Foods such as berries, green tea, red wine, and pomegranates can have protective
or preventative effects against prostate cancer. These types of foods contain anti-oxidants which
can shield prostate cells from the detrimental consequences of oxidation. Additionally, altering
sources of protein from red meat to fish, soy, or beans is a preventive factor that reduces the
chances of developing prostate cancer. Vegetables, such as carrots and broccoli, and fresh fruit
such as tomatoes, have lycopene, beta carotene, and variety of vitamins and minerals which may
also play a role in preventing prostate cancer (Prostate Cancer Treatment Guide, 2010).
Adequate amounts of selenium have also been found to reduce the risk of prostate cancer
(Prostate Cancer Treatment Guide, 2010). Studies conducted on animals suggest that higher
intake of selenium reduces the risk of prostate cancer. Selenium offers protection against prostate
cancer because it is a significant part of antioxidant enzymes and an important element in
immune system function (Stein & Colditz, 2004).
Men from Japan, Italy, and Greece who maintain a diet rich in fresh fruits, vegetables,
fish, rice, green tea and olive oil have a lower incidence rate of prostate cancer. However as these
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men migrate to the US and become acculturated, they tend to change their dietary habits,
consuming larger amounts of western food, thus increasing their risk of developing prostate
cancer (Prostate Cancer Treatment Guide, 2010). Lastly, geographic locations have been linked
with a lower risk of developing prostate cancer. Research has shown that the lower rate of
prostate cancer in some geographic regions such as Japan has less to do with lifestyle, and more
to do with customary diets and geographic location.
Geographic Location
The US, Canada, Australia, and most Western European countries have the highest
prevalence, incidence, and mortality rates of prostate cancer globally. Conversely, Japan, Italy,
and Greece have the lowest rates of developing and dying from the disease. The highest
mortality rates of prostate cancer are found in countries with the high latitudes and low levels of
ultraviolet (UV) light such as Canada and Sweden (Prostate Cancer Treatment Guide, 2010).
Multiple studies have attributed the risk of prostate cancer on UV light in addition to
dietary habits (Prostate Cancer Treatment Guide, 2010). Insufficient exposure to UV light may
increase the mortality rate of prostate cancer. UV light stimulates the production of vitamin D,
which reduces the risk of prostate cancer development. There is considerable evidence, in vitro
and in vivo, for the anticancer effects of UV light on prostate cancer. Multiple case control
studies conducted in prostate cancer have shown that adequate exposure to UV light and levels
of vitamin D are related to a decreased level of prostate cancer risk (Moon, Fryer, & Strange,
2005).
African American men have the highest incidence and mortality rate of prostate cancer in
the world (Reddy, Shapiro, & Brawley, 2003). The reason for this high rate is unclear although it
is believed that it may be due to African American men not receiving adequate UV light due to
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their increased levels of skin melanin, which blocks some UV exposure (Prostate Cancer
Treatment Guide, 2010). Despite the changes men can make to reduce their chances of
developing prostate cancer prevention, non-modifiable risk factors are unchangeable.
Non-Modifiable Risk Factors
Family History & Genetic Factors
Data from a twin study propose that approximately 42% of the risk of developing prostate
cancer may be attributed to genetic factors (Hsing & Chokkalingam, 2006). Research shows that
a family history of prostate cancer increases a male's chance of developing the disease by twenty
to thirty percent, principally if the family member is a brother, father, or son (Stanford &
Ostrander, 2001). The genetic factors related to prostate cancer includes BRAC 1 & 2 genes,
hereditary prostate cancer X (HPCX), and the perlecan gene.
BRAC 1 & 2 genes are thought to be related to predisposing a person to developing
prostate cancer. They are classes of genes known as tumor suppressors. Under normal conditions
the genes function to thwart the genetic alteration of cells that induce the inception of cancer by
slowing or stopping the proliferation of cells when the DNA of cells become damaged, which
gives the cells the opportunity to repair errors in DNA before they continue to proliferate leading
to cancer. The risk of developing prostate cancer increases with the mutation of either of these
genes. An alteration specifically in the BRAC 1 gene enhances the risk of developing prostate
cancer in males over sixty five years old. Alternatively, younger men under sixty five risk
increases with mutations in the BRAC 2 gene (National Institutes of Health, 2009b).
The perlecan gene is also thought to play a part in the onset of prostate cancer. It is
localized on a region of DNA that is normally mutated in prostate cancer patients. Depending on
the needs of the body, the proteins function in signaling cell proliferation can be turned off and
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on. However, at the onset of prostate cancer, the cells consistently receive proliferation signals,
which in turn promote the advancement of prostate cancer (Datta et al., 2006). Since the
development of prostate cancer appears to the result of multiple complex interactions ranging
from lifestyle to genetics, family history is an appropriate genomic tool that captures these
interactions (Ahn et al., 2008).
Family history is a fundamental public health instrument for the identification of
individuals who are at high risk for developing a particular disease, such as prostate cancer. It
can be essential to individualized cancer prevention strategies (Ahn et al., 2008). A family
history of prostate cancer was initially defined as prostate cancer meeting three criteria: prostate
cancer within three consecutive generations, two relatives diagnosed with the disease before the
age of fifty five, or three or more family members diagnosed with the disease. However, it was
later suggested that this criteria would exclude families with autosomal recessive or X-linked
transmission of the disease (Delongchamps, Singh, & Hass, 2006).
Multiple studies have consistently shown that a family history of prostate cancer increases
the risk of developing the disease (Hsing & Chokkalingam, 2006). The hereditary form of
prostate cancer comprises an estimated five to six percent of reported cases. Thirty-three percent
of prostate cancer cases diagnosed before age sixty are hereditary. Evidence has shown that
prostate cancer is genetically heterogeneous. Several genes located on the human prostate cancer
1 chromosome have been linked to hereditary prostate cancer carcinogenesis (Delongchamps,
Singh, & Hass, 2006).
Men who have a first-degree male relatively with a history of prostate cancer are two to
three time more likely to develop the disease (Hsing & Chokkalingam, 2006). A first-degree
relative is a family member such as a father, sibling, or child. In a ten year prospective cohort
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study, it was found that men with a positive family history of prostate cancer were over four
times more likely to have the aggressive form of the disease when diagnosed. Some studies have
found that the risk of developing prostate cancer is three times greater for men with siblings who
have a history of prostate cancer than their parental history (Ahn et al., 2008). Additionally,
African American men with a family history of prostate cancer have twice the risk of developing
the disease than Euro-American men (Bloom, Stewart, & Oakley-Girvans, 2006).
Race/Ethnicity/Nationality
In the US, prostate cancer is sixty-six percent more likely to develop in African American
men compared to men of different races. Chinese and Japanese men tend to have some of the
lowest rates of prostate cancer when compared to African American and Caucasian men (Hsing
& Chokkalingam, 2006). African American men are twice as likely to die from the disease
compared to Caucasian men. In contrast, black men living in Africa have a lower rate of prostate
cancer when compared to black men globally. A cohort study comparing the outcomes of 396
Caucasian American and 524 African American for ten years found that the mortality rate for
prostate cancer was higher in African American men, especially in those under the age of
seventy. This higher incidence and mortality rate of prostate cancer in African Americans has
been linked to a lower literacy rate, genetics, diets high in saturated fat, and lack of access to
medical care (Hsing & Chokkalingam, 2006).
African Americans with prostate cancer are unlikely to seek treatment. Studies have
shown that similar treatments among different racial groups yield similar results. For instance,
African American men who have equal access to health care compared to Caucasian men and a
higher literacy rate tend to have a comparable incidence and mortality to Caucasian men (Reddy,
Shapiro, & Brawley, 2003).
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Compared to Caucasians, the proportion of African Americans with an aggressive form
of prostate cancer is significantly higher. Multiple studies show that there is only a small
difference in prostate cancer survival among African American men and Caucasian men who are
comparably treated (Reddy, Shapiro, & Brawley, 2003). Ethnicity is a consistently observed but
less understood risk factor of prostate cancer (Hsing & Chokkalingam, 2006). Lastly, all men
regardless of their race are at greater risk of developing the disease beyond the age of fifty
(Delongchamps, Singh, & Hass, 2006).
Age
Prostate cancer is known as the cancer of middle age and older men. Age is a strong risk
factor for prostate cancer; men under the age of fifty are rarely diagnosed with the disease.
However, beyond this age prostate cancer incidence increases exponentially (Delongchamps,
Singh, & Hass, 2006). The specific role age plays in the development of the disease is unclear.
However, research has provided evidence that prostate cancer arises from age related changes in
the glandular epithelium of the prostate. Caucasian American men, aged 75 to 79, have
approximately one hundred and thirty times the risk of developing the disease compared to
Caucasian American men aged 45 to 49; several studies examining the genetic changes in
prostate cancer tissue, suggest that damage to DNA with age may to some extent explain this
trend. A study conducted on the age-related changes in 795 deceased African American men
from Washington DC, did not find a relationship between tissue changes related to aging and the
presence of prostate cancer (Delongchamps, Singh, & Hass, 2006). Many changes take place in a
male's body as aging occurs. Several of these alterations are due to the level of circulating
hormones throughout the body which increases their risk for developing prostate cancer.
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Hormonal Factors
The growth and preservation of the prostate depends on testosterone and the conversion
of dihydrotestosterone. However, the specific role hormones play in the etiology of prostate
cancer is unclear. In laboratory studies, it was found that the administration of testosterone to rats
induces prostate cancer and encourages cell growth and hampers prostate cell death. Additional
studies suggest that high levels of testosterone and dihydrotestosterone, and low levels of
estrogen may potentially elevate the risk of developing prostate cancer (Hsing & Chokkalingam,
2006).
IGFs have also been linked to prostate cancer. IGFs originate within the liver and consist
of two hormones, IGF-1 and IGF-2, which play an important role in cellular growth and
metabolism. Two case control studies conducted, found a strong association between the levels
of IGFs circulating in the body and the risk of developing prostate cancer. The results from these
studies were also substantiated in a Physician Health Study, in which a direct relationship was
found between the development of prostate cancer and IGF-1 levels. Males in the top twenty-five
percent of IGFs circulating throughout their bloodstream had greater than four times the risk of
developing prostate cancer compared to males in the bottom twenty-five percent. To date IGF's
are identified as the strongest risk factor for prostate cancer (Hsing & Chokkalingam, 2006).
In a meta-analysis of fourteen case control studies, a forty-seven percent increase in the
risk of developing prostate cancer was reported with an elevated level of IGF-1 (Wiggle, Turner,
Gomes, & Parent, 2008). In addition six meta-analysis studies reported a forty-nine percent
increase in the risk of developing prostate cancer in men with elevated levels of IGF-1 (Renehan
et al., 2006). In a case control study, a dose response relationship was found between prostate
cancer and IGF-1 levels. This relationship between prostate cancer and IGF-1 appeared to be
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stronger for men under the age of fifty-nine and for men with advance cases of prostate cancer
(Stattin et al., 2004).
Lastly, vitamin D is a steroid hormone obtained primarily from sunlight exposure. It is a
preventative hormone that protects the cells of the prostate from over production and death.
Additionally, vitamin D has been found to hinder prostate growth in a living organism (Hsing &
Chokkalingam, 2006).
Despite the modifiable and non-modifiable risk factors associated with the disease, the
symptoms associated with the cancer and treatments used are similar.
Symptoms & Treatment of Prostate Cancer
The majority of men with prostate cancer do not have accompanying symptoms. Many
prostate cancer cases are normally discovered during a prostate biopsy, which is performed after
a serum PSA blood test is done, or by a digital rectal examination. These examinations are part
of the screening process for prostate cancer. The symptoms of prostate cancer normally include
difficulty urinating, increased urination accompanied by pain, and/or urinary retention. Some
men may feel a sense of bladder fullness after urination because their bladder has not been fully
emptied. A few less common symptoms in the early stages of prostate cancer include painful
ejaculation, or impotence. These symptoms alone do not suggest or confirm the presence of
prostate cancer. Many of these symptoms can occur in men with a benign enlargement of the
prostate (National Institutes of Health, 2009a).
Treatment for the disease depends on multiple factors such as a person's age, current
medical conditions, and the scope of the tumor; for example, the risk of older men with chronic
conditions having surgery to treat the disease greatly outweighs the benefit. There are six
standard types of treatment used for patients with prostate cancer which includes: watchful
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waiting, surgery, radiation therapy, hormone therapy, chemotherapy, and biologic therapy
(National Institutes of Health, 2009a).
Watchful waiting is normally used on older patients with medical conditions and who are
in the early development of the disease. It entails withholding treatment and observing the
progress of a patient's condition to assess whether the symptoms change for the better or worse.
Surgery as an option for prostate cancer treatment is normally offered to patients in overall good
health. The types of surgery offered includes: pelvic lymphadenectomy, which entails the
removal of the lymph nodes in the pelvis to asses if they are cancerous and radical
prostatectomy, which entails removal of the prostate, surrounding tissue and seminal vesicles.
Additional treatments include radiation therapy to kill cancerous cells; hormone therapy, which
removes hormones or prevents their action while slowing or stopping the growth of cancerous
cells; chemotherapy, which uses medication to impede the development of cancerous cells; and
biologic therapy, which utilizes the patient's immune system to battle the disease by the use of
substances developed by the body or synthetic substances to directly boost, or restore the body's
innate defense against the disease (National Institutes of Health, 2009a). Another type of
treatment includes brachytherapy, which is a treatment using a radioactive source situated inside
or close to the cancerous tissue (Sadetsky, Elkin, Latini, DuChene, & Carroll, 2008).
Knowledge of the modifiable and non-modifiable risk factors, symptoms, and treatment
of prostate cancer can assist in the development of strategies to increase the survival rate by the
stage of diagnosis.
Prostate Cancer Survival by Stage at Diagnosis
The stage of prostate cancer at diagnosis is a vital determinant of the relative survival
among those with the disease (Hamilton & Ries, 2007). Prognosis of prostate cancer is strongly
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related to the stage, with a five year relative survival rate of 100% among men diagnosed with
localized (confined to primary site) or regional (spread to regional lymph nodes) prostate cancer
and 31% among men diagnosed with distant (cancer has metastasized) prostate cancer (Fedewa,
Etzioni, Flanders, Jemal, & Ward, 2010). A 100% relative survival rate means that men
diagnosed with prostate cancer do not have excess mortality compared to men of a similar age
and race (Hamilton & Ries, 2007).
In a twelve year prospective cohort study, it was confirmed that there is a 100% relative
survival rate for localized and regional prostate cancer cases for males of all races within for the
first five years of diagnosis. However, African American men survival rate decreases slightly
after three years of diagnosis due to metastasis or distance disease, compared to Caucasian
Americans. Additionally, men diagnosed with prostate cancer under the age of sixty-five tended
to have a lower survival rate compared to men diagnosed between the age of sixty-five and
seventy-four years of age. The relative five year survival rate for all males between the age of
twenty and seventy-five after diagnosis, by geographic location in the US was 100% for
localized disease, 96% for regional disease, and 35.4 % for distant disease. However, the rural
areas of Georgia accounted for the lowest survival rate during the fifth year after diagnosis
(Hamilton & Ries, 2007).
Populations based studies consistently show that African American men living in the US
are more likely to be diagnosed with an aggressive form of prostate cancer and have a lower five
year survival rate than men of other races when the disease is diagnosed at the same stage.
Japanese American and Chinese American men tend to have higher survival rates of prostate
cancer compared to both African American and Caucasian American men when they are
diagnosed at a similar disease stage (Girvan et al., 2003). African American men are less likely
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to be diagnosed with prostate cancer at a localized stage, when the disease can be successfully
treated, and are more likely to be diagnosed at a distant stage when the cancer has spread to other
regions of the body (Jemal et al., 2011).
Advance stages of prostate cancer are the primary factor behind the poor survival rate.
Access to and use of health care services may partially account for the poor survival rate of the
disease. Lack of access to health care may be influenced by economic, social, and cultural factors
that differ by race and nationality. Men of various races and/or nationalities may find difficulty
in pursuit of adequate health care due to language barriers, specific cultural practices pertaining
to medical care, and their socioeconomic status (SES). SES is associated to the usage and access
of health care. Lower SES is related to a limited and a more uncommon use of health care
services, and a higher incidence and mortality of prostate cancer (Girvan et al., 2003).
Research among African American and Caucasian men indicate that SES may partially
account for some or all of the racial difference in prostate cancer stage of diagnosis and survival.
Additionally, aging increases the risk of developing prostate cancer and co-morbid conditions.
Multiple studies among men with prostate cancer have found that co-morbid conditions influence
the survival of men with prostate cancer by changing their treatment options (Girvan et al.,
2003). Additionally, multiple studies have confirmed that insurance status is strongly related to
prostate cancer severity among males of all races.
Primary Payer
Men who have health insurance are less likely to die from prostate cancer (Fedewa et al.,
2010). Insurance status plays a vital role in receiving specific treatments, education, counseling
services, and screening activities for prostate cancer (Sadetsky et al., 2008). The stage of prostate
cancer among uninsured or Medicaid insured men is correlated with lower access to healthcare
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services and the utilization of PSA testing. In a study conducted between 2004 and 2006, among
men diagnosed with prostate cancer, found that uninsured and Medicaid insured men are more
likely to have elevated PSA levels (Fedewa et al., 2010).
Studies that examine the relationship between insurance, types of treatment, and prostate
cancer survival, have yielded mixed results. In a study conducted, on Health Maintenance
Organization (HMO) and Free-for-Service (FFS) Medicare patients, concluded that HMO
patients diagnosed with prostate cancer between 1985 and 1992 were likely to receive aggressive
treatment compared to patient in the FFS groups (Sadetsky et al., 2008). Another study,
examining the patterns of treatments for men diagnosed with prostate cancer with and without
insurance, found that older Caucasian men with private insurance were more likely to receive
radical prostatectomy, and radiation therapy than other men in the study (Wu et al., 2005).
A study examining whether the type of treatment men diagnosed with prostate cancer
received differed by their type of insurance. Of the 13,124 men enrolled in the study twentythree percent were insured by Medicare, forty-forty percent were insured by Medicare plus a
supplemental insurance such as Preferred Provider Organization (PPO), HMO, or FFS, and the
remaining men were insured by HMO, PPO, or Veterans Affairs (VA). They found that men in
the HMO, PPO, and VA group were more likely to receive hormonal treatment, and
brachytherapy than radical prostatectomy when compared to men with Medicare only, Medicare
and FFS, and Medicare and PPO. It was also found that men with VA coverage had the worst
survival rate and were likely to have an aggressive form of prostate cancer at diagnosis (Sadetsky
et al., 2008).
The specific role insurance plays in receiving specific prostate cancer treatment remains
uncertain. However, it has been suggested that insurance type influences the type of medical care
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received through multiple mechanisms such as receiving services in a timely manner, receiving
appropriate services which suits the patients' needs, and the access to continuity of care
(Sadetsky et al., 2008).
Insurance status is an important determinant in the different types of treatments received
for prostate cancer (Sadetsky et al., 2008). In a 2007 study, analyzing America's uninsured
population, it was found that fifty-five percent of males were uninsured, with sixty-two percent
voluntarily uninsured, and fifty percent involuntarily uninsured. Uninsured men are unlikely to
receive the appropriate treatment in a timely manner, thus increasing their odds of developing
and dying from prostate cancer (O'Neill & O'Neill, 2007).
Global Incidence & Mortality Rate Trends
The effects of prostate cancer fluctuate among men throughout the world with a varying
mortality and incidence rate. Globally, the incidence rates for African Americans ranks amongst
the highest (185.4 per 100,000 individuals annually), followed by Caucasian Americans (107.8
per 100,000 individually annually). The incidence rates in Brazil and the Caribbean tends to be
higher in areas where there are larger populations of African descent (94 per 100,000 individuals
annually). On the other hand, in some parts of Central America the incidence rate of prostate
cancer are much lower in comparison (35 per 100,000 individuals annually) (Jemal et al., 2005).
The incidence rates in Europe vary greatly, with the lowest rate in Eastern Europe (15 to
36 per 100,000 individuals annually) and the highest in Western Europe, specifically in Austria
(15 to 100 per 100,000 individuals annually). In Asia, the incidence of prostate cancer is much
lower in comparison to the rest of the world. However, there is considerable variation within the
more westernized countries such as Israel, Japan, and the Philippines (22 to 47 per 100,000
individuals annually). Conversely in China, India, Pakistan, Shanghai, and Thailand the
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incidence race is much lower (3 to 7 per 100,000) in comparison (Hsing & Chokkalingam,
2006).
The mortality rates tend to be higher in the Western nations and lower in Asian countries
such as Korea, Japan, South Korea (2 to 5 per 100,000 individuals annually). Mortality rates are
found to be higher in Scandinavian countries and northern Europe (19 to 23.6 per 100,000
individuals annually) compared to the US (14 per 100,000 individuals annually). The highest
prostate cancer mortality rates are found Caribbean nations of Barbados, Trinidad and Tobago,
and the Bahamas where a large portion of men are of African descent (Jemal et al., 2005).
Incidence & Mortality Rate Trend in the US & Ohio
One in six men in the US who are diagnosed with prostate cancer will pass away within a
few years of diagnosis (Jemal et al., 2005). It is estimated that 241,740 men will be diagnosed
with and 28,170 men will pass away from prostate cancer in 2012. According to 2007 to 2009
rates, approximately sixteen percent of men born in this generation will be diagnosed with
prostate cancer at some point during their life (Howlader et al., 2012). The trend in the incidence
rate throughout the US for all races from 2000 and to 2009 has decreased by 1.9%. The trend in
mortality rate for prostate cancer for all races throughout the US from 1994 to 2004 decreased by
3.9%, and from 2004 to 2009 decreased by 3.2% (Howlader et al., 2012).
Prostate cancer affects about 1 out of every 11 Caucasian men, and 1 out of every 9
African American men in the US. In 2009, there were approximately 27,360 deaths attributed to
prostate cancer with 192,280 new cases of the disease in the US (Jemal et al., 2009). During
2001 to 2005 the average annual age adjusted prostate cancer incidence rate in the US was 169.4
per 100,000 males (Ohio Department of Health, 2012). During that time period, the average
annual age adjusted prostate cancer incidence and mortality rate in the State of Ohio was 145.7
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per 100,000 males or 7,706 new cases and 27.8 per 100,000 males or 1262 deaths respectively
(Ohio Department of Health, 2012).
From 2005 to 2009, the median age at diagnosis and mortality for prostate cancer was
sixty-seven and eighty years old respectively (Howlader et al., 2012). Men who were diagnosed
and died between the age of 35 and 44 accounted for 0.6% and 0.1% respectively; 45 to 54
accounted for 9.5% and 1.5% respectively; 55 to 64 accounted for 31.6% and 8.0% respectively;
65 to 74 accounted for 35. 5% and 19.8% respectively; 75 to 84 accounted for 18.6% and 38.6%
respectively; and 85 years and above accounted for 4.1% and 32.0% respectively. During those
years the incidence and mortality rate for all races was 154.8 and 23.6 per 100,000 men
respectively; 146.9 and 21.7 per 100,000 Caucasians men respectively; 236 and 53.1 per 100,000
African Americans men respectively; 85.4 and 10 per 100,000 Asian/Pacific Islanders men
respectively; and 125.9 and 17.8 per 100,000 Hispanics men respectively (Howlader et al.,
2012).
Prostate cancer in Ohio is the second leading cause of cancer deaths among men,
following lung cancer. It is the most frequent invasive cancer diagnosed in men living in Ohio. It
represents 10% of all male cancer deaths. African American men in Ohio are two times as likely
to pass away from the disease, compared to Caucasian men. Prostate cancer death rates
decreased by 39.8% for Caucasian men and 35.9% for African American men throughout the
state from 1992 to 2006 (Ohio Department of Health, 2009).
The average annual population for Montgomery County during 2001 to 2005 was
550,564, of which 73% was age 20 and older and 31% was age 50 and older. Additionally, the
population was 48% male and 21% African American men. During that time period the
Montgomery County prostate cancer incidence and mortality rate for all males was 140.8 per
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100,000 males or 2796 new cases and 25.5 per 100,000 males or 1,228 deaths respectively,
which was lower than the state of Ohio incidence and mortality rate and the US incidence and
mortality rate of 163.0 per 100,000 males and 26.7 per 100,000 males respectively (Ohio
Department of Health, 2009).
Methods
A descriptive study of prostate cancer was conducted on Montgomery County men using
the Ohio Cancer Incidence and Surveillance System (OCISS) Data, 2000-2009. The OCISS data
was obtained from the faculty adviser overseeing the study from the Ohio Department of Health,
and was used to determine the incidence and mortality rate, the current trend, and a descriptive
analysis of men with of prostate cancer in the county. The data was compared to other counties
of similar demographics, Ohio, and the US. Approval for this study was granted by Wright State
University Institutional Review Board on April 20, 2012.
The primary prostate cancer prevention factors assessed for Montgomery County men
includes: the average annual population estimates from 2000-2009; a socioeconomic profile of
men living in Montgomery county; prostate cancer related risk factors such as primary payer,
PSA testing, heavy drinking, smoking, weight, and fruit and vegetable consumption; an in-depth
analysis of men age 35 and older who consume less than five servings of fruits and vegetables;
and an in-depth analysis of men who reported having a PSA test within the last two years.
Secondary data sources accessed for incidence, mortality and trend analysis are listed below:
•

United States Census Bureau

•

Surveillance Epidemiology and End Results

•

Ohio Health Jurisdiction Cancer Profiles, Ohio Cancer Incidence Surveillance
System, Ohio Department of Health

•

2009 Behavioral Risk Factor Surveillance System
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2008 Healthy Ohio Community Profiles

•

National Cancer Institute
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The total number of men over the age of 18 who consume less than 5 servings of fruits
and vegetables per day living in Montgomery County in 2007 was used to calculate the other
years for Montgomery County. The 2007 percentage was retrieved from the Montgomery
County Health Assessment 2010. The percentage of men who consume less than 5 serving per
day in 2007 was divided by the percent who consume less than 5 servings in Ohio in 2007. It was
then multiplied by the other Ohio years to determine the percentages for Montgomery County.
The total number of men over the age of 40 who received a PSA test in Montgomery
County was used to calculate the other categories for Montgomery County. This percentage was
retrieved from the BRFSS. The total number of men living in Montgomery County was divided
by the total number for Ohio and multiplied by the other Ohio categories to determine the
percentages for Montgomery County.
The early detection factors assessed for Montgomery County include: incidence and
mortality rates for prostate cancer; incidence and mortality rates for all cancer sites; prostate
cancer incidence, mortality, screening, and late stage diagnosis; the average annual numbers and
the percent of prostate cancer cases in the county; the trend of invasive prostate cancer incidence
compared to other counties; prostate cancer by grade, age group and race; and prostate cancer
incidence rate by staged at diagnosis. Secondary data sources for the early detection factors are
listed below:


Ohio Cancer Incidence Surveillance System, Ohio Department of Health



Ohio Public Information Warehouse, Ohio Department of Health

MONTGOMERY COUNTY PROSTATE CANCER


37

Cancer Incidence and Mortality among Ohio Residences, 2003-2007. Ohio
Cancer Incidence Surveillance System, Ohio Department of Health, August 2010.

Additionally, the Ohio Cancer Incidence and Surveillance System (OCISS) data for men
living in Montgomery County with prostate cancer was used to calculate the incidence and
prevalence of prostate cancer by the stage at diagnosis.
A descriptive analysis was created with the data acquired from the OCISS. The variables
used included marital status, city, zip code, race, gender, age of diagnosis, and primary payer at
diagnosis.
Results
Primary Prevention Factors
Table 1. Average Annual Population Estimates for Montgomery County by Age Group,
Gender, and Race, 2000-20091,3,4
Age Group
Gender
Race
Total
2
Population
Male
Female
Caucasian
African
American
<20
73,639
70,655
99,890
36,889
144,294
20+
187494
211,071
312,585
73,394
398,565
40+
116,902
144,668
204,464
44,468
261,570
50+
78,433
104,071
144,311
30,002
182,504
All ages
261,133
281,726
412,475
110,283
542,859
1

The 2000-2009 population estimates for Montgomery County Ohio was determined by averaging the postcensal
estimates for
July 1, 2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009 U.S. Census Bureau, 2010.
2
Total population includes whites, blacks, and all additional races.
3
Vintage 2006 postcensal estimates for July 1, 2001-2005, U.S. Census Bureau, 2007
4
Data Source: Census 2000 - 2009 Demographic Profiles, U.S. Census Bureau, Summary File 1(SF1)

The 2000 to 2009 average annual population, presented in Table 1, for Montgomery
County is 542, 859, of which 48 percent are age 40 and older and 34 percent are age 50 and
older. The population is 48 percent male, 52 percent female, 76 percent Caucasian, and 20
percent African American. Nationally and in Ohio, prostate cancer incidence rates are higher
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among African American men compared to Caucasian men. Additionally, the risk of prostate
cancer increases with age.
Table 2. Socioeconomic Profile of Montgomery County with Comparison to Ohio & the US1,2
Socioeconomic Indicators
Median Earnings for Male Full-Time,
Year-Round Workers ($)
Median Household Income ($)
% Families Below Poverty Level
% No High School Diploma (Age 25+)
% Uninsured3

Montgomery
County
45,680

Ohio

US

46,106

46,478

56,559
11.7%
9.0%
12.4%

59,680
10.3%
9.2%
18.5%

62,982
10.1%
8.7%
16.7%

1

Table adapted from Montgomery County Cancer Profiles, Ohio Cancer Incidence Surveillance System, Ohio
Department of Health, 2008.
2
Data Source: U.S. Census Bureau, 2006-2010 American Community Survey.
3
Percent of uninsured adults in Ohio Counties: Ohio Family Health Survey (Adults 18-64), 2008.

Socioeconomic indicators related to the risk of developing and dying from prostate
cancer in Montgomery County, Ohio, and the US are presented in Table 2. The factors include:
median earnings for male full-time year round workers, median household income, percentage of
families below the poverty level, percentage of people who did not attain a high school diploma,
and those who are uninsured. The median earnings for male full-time workers in Montgomery
County is approximately on par with Ohio and the US; however the median household income is
considerable less when compared to Ohio and the US. Montgomery County has a higher
percentage of families living below the poverty level compared to Ohio and the US. The
percentage of people without a high school diploma in the county is higher than the national
percentage, but lower than Ohio. Lastly, Montgomery County has a lower percentage of
uninsured people compared to Ohio and nationally.
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Table 3. Prostate Cancer and Cancer Related Health Behaviors/Risk Factors1
% of Men
%
%
%
%
age 40+
<5
Heavy
Current
Over
who had a
Fruit/Veg Drinkers Smokers
weight
PSA test in
the past 2
years2
Montgomery
538,104
56.0
77.7
5.3
23.2
38.3
Lucas
441,910
56.0
82.3
5.1
24.4
35.7
Stark
378,664
61.8
78.4
4.3
24.5
35.8
Summit
543,487
58.9
77.2
5.7
21.8
36.6
Ohio
11,466,917
54.6
79.2
5.5
23.1
35.4
US
301,621,159
54.8
75.7
5.2
19.7
36.7
1
Data Source: 2007 Ohio Behavioral Risk Factor Surveillance System (BRFSS), ODH
2
2008 data used from Ohio Behavioral Risk Factor Surveillance System (BRFSS), ODH
County

2007
Population

%
Obese

% No
physical
Activity

23.1
30.6
28.5
26.3
28.1
26.3

47.6
50.4
50.1
49.7
50.0
50.8

There is not large variation among the counties listed with regards to the percent of
people who consume less than five fruits or vegetables per day, the percent of current smokers,
the percent of overweight and obese, and the percent of physical inactivity. Montgomery County
has the highest percentage with regards to the percent of overweight people compared to the
national average, the State of Ohio, and the other counties. Compared to the national average,
Montgomery County is approximately four percentage points higher for those who smoke
tobacco, and three percentage points lower for those who are considered obese.
Montgomery County also has a larger percentage of people who eat less than five fruits
or vegetable servings per day compared to the national average. Additionally, Montgomery
County is above the national average for the percent of men, age forty and older, that have had a
PSA test within the last two years. Age is a strong risk factor for prostate cancer; men under the
age of fifty are rarely diagnosed with the disease.
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Table 4. % of Men 35+ who reported consuming less than 5 servings of fruits/vegetables per
day, 2000-20091
Year
2000
2001
2003
2005
2007
2009

% of Men who consume less than 5 servings per day
US
Ohio
Montgomery County2
81.1
82.3
81.6
79.9
77.1
76.5
82.4
81.4
80.7
81.4
81.9
81.2
80.6
84.7
84.03
80.8
82.9
82.2

1

Data Source: 2010 Ohio Behavioral Risk Factor Surveillance System (BRFSS), ODH
Data includes men 18 years and older
3
Data Source: Montgomery County Community Health Assessment 2010
2

A diet rich in fresh fruits and vegetables, serves as a protective factor that may lower
incidence rate of prostate cancer. The percentage of men from 2000-2009 who consume less than
five servings of fruits/vegetables per day in Montgomery County was estimated from the Ohio
BRFSS data. There was not a huge disparity among men consuming less than 5 servings of fruits
and vegetables within the past ten years in Montgomery County compared to Ohio, and
nationally. However, during that period, Montgomery County had slightly more men on average
who consume less than 5 servings of fruits and vegetables compared to the national average.
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Table 5. % of Men 40+ who reported having had a Prostate Specific Antigen (PSA) test1
% of Men age 40+ had a PSA test in the past 2 years
US

Ohio

Montgomery
County2

40-49
50-59
60-64
65+

26.0
56.1
72.5
76.2

24.7
56.1
72.4
79.3

25.3
57.4
74.1
81.2

Caucasian
African American
Hispanic
Other

54.8
58.8
40.6
43.4

55.0
57.5
N/A
N/A

56.3
58.9
N/A
N/A

Education
Less Than High School
High School or GED
Some College
College Graduate

40.4
49.3
54.3
59.6

40.2
51.3
54.8
59.4

41.2
52.5
56.1
60.8

Annual Household Income
< $15,000
$15,000 - 24,999
$25,000 - 49,999
$35,000 - 49,999
$50,000+

36.5
47.3
52.9
56.1
55.7

33.9
56.5
57.8
57.3
55.0

34.7
57.9
59.2
58.7
56.3

Total (Men 40+)

53.2

54.4

55.73

Category
Age

Race

1

Data Source: 2010 Ohio Behavioral Risk Factor Surveillance System (BRFSS), ODH
Data Source: Estimated based on Ohio data
3
Data Source: 2010 Ohio Behavioral Risk Factor Surveillance System (BRFSS), ODH
2

The PSA test measures the level of PSA in the blood. The test was approved by the US
Food and Drug Administration (FDA) to help detect prostate cancer in men age 50 and older.
Table 4 shows percentage of men age 40 and older nationally, in the state of Ohio, and
Montgomery County who reported having a PSA test within the last two years. The percentages
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for Montgomery County were estimated based on the 2010 BRFSS estimates for Ohio. From the
Montgomery County estimates, the frequency of men who had a PSA test within the past two
years increased with age. There was only a slight difference in PSA testing by race. Male college
graduates were more likely to have had a PSA test than men with less than a high school
education. Lastly, there was great disparity in PSA testing between men who have an annual
income of less than $15,000 per year and men whose annual income in greater than $15,000
annually.
Early Detection Factors
Table 6. Average Annual Number and Age-adjusted Rates of Invasive Cancer Cases and
Cancer Deaths for All Sites/Types in Montgomery County with Comparisons to Ohio and the
US, 2003-20071, 2
All Cancer Sites/Types
County3
Montgomery
Lucas
Stark
Summit
Ohio
United States

Cases
2,909
2,213
2,048
2,815
29,591
-

Incidence
Rate per 100,000
473.2
476.3
453.6
460.9
470.0
461.6

Cases
1,210
982
862
1,240
12,859
-

Mortality
Rate per 100,000
193.7
208.8
184.5
199.2
199.6
183.8

1

Source: Chronic Disease and Behavioral Epidemiology and the Vital Statistics Program, Ohio Department of
Health, 2010; National Center for Health Statistics Public Use Mortality Data published in SEER Statistics Review
1975-2007, National Cancer Institute, 2010
2
Average annual rate per 100,000, age-adjusted to the 2000 US standard population
3
Source: Ohio Cancer Incidence Surveillance System, Ohio Department of Health, 2010

Montgomery County cancer incidence rate for all sites/types combined was 473.2 cases
per 100,000 individuals or 2,909 cases per year from 2003 to 2007. This rate is second only to
Lucas County (476.3 cases per 100,000 individuals), and higher than the incidence rate for Ohio
and the US (Table 6). The mortality rate for cancer mortality for all sites/types accounted for
193.7 cases per 100,000 individuals, which is higher than the national rate (183.8 cases per
100,000 individuals), but lower than the rate in Ohio (199.6 per 100,000 individuals).
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Montgomery County mortality rate for all site/types ranked third behind Lucas and Summit
Counties.
Table 7. Prostate Cancer Incidence, Mortality, Screening, and Late Stage Diagnosis for
Montgomery and comparison counties, Ohio, and the United States, 2003-20071, 2
Rate per 100,000
County

Montgomery
Lucas
Stark
Summit
Ohio
United States3

2007 Population

Incidence1

Mortality1

538,104
441,910
378,664
543,487
11,466,917
301,621,159

151.4
147.7
154.5
135.2
145.5
156.9

23.1
24.5
23.5
31.1
26.2
24.7

Percent
Men age 40+ who
had a PSA test in the
past 2 years2
56.0
56.0
61.8
58.9
54.6
54.8

Late
Stage
DX1
9.0
10.0
11.0
11.0
10.0
4.2

1

Source: Ohio Cancer Incidence Surveillance System, Ohio Department of Health, 2010
Source: Ohio Behavioral Risk Factor Surveillance System (BRFSS), Ohio Department of Health, 2008
3
Data source: Surveillance Epidemiology and End Results (SEER) Program, National Cancer Institute (US data),
2008
2

From 2003 to 2007, Montgomery County had the third highest prostate cancer incidence
compared to Ohio, the United States, and other counties in Ohio with comparable population
sizes and demographics. From 2003 to 2007, Montgomery County had the lowest prostate cancer
mortality rate (23.1 per 100,000) compared to the other counties, Ohio, and the US. Additionally,
Montgomery County had the third highest percent of males who had a PSA test within the last
two years. Montgomery County had a lower percentage of men who were diagnosed with
prostate cancer at a late stage than the Ohio average.
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Figure 1: Prostate Cancer: Age specific Proportions (%) by Race in Montgomery County,
2000-2009a

40.0
35.0

Percent

30.0
25.0

Caucasian

20.0

African
American
Other/Unknown

15.0
10.0
5.0
0.0
>40

40-49

50-59

60-69

70-79

80+

Age
a

Data Source: Ohio Cancer Incidence Surveillance System (OCISS), 2008-2009

Figure 1 shows the 2000 to 2009 age-specific proportions for prostate cancer by race.
Virtually all of the prostate cancer cases diagnosed in Montgomery County during that time
period were among men age 40 and older. Among Caucasian men, the proportion of prostate
cancer increased with advancing aging starting from the 40-49 age group, peaking at the 60-69
age group, and declining beyond that age group. A similar trend can be seen with the African
American men age group. Among men classified as other/unknown, prostate cancer incidence
rates increased with advancing aging, starting from the 40-49 age group, but peaking at the 70-79
age group. Overall, the proportion of prostate cancer increases for all races beyond the age of 40.
However, the proportion begins to decrease between the age of 60 and 79 for all races.

In situ

Localized

Regional

Distant

Unstaged/Unknown

Total

Cases

Percent

Cases

Percent

Cases

Percent

Cases

Percent

Cases

Percent

Cases

Montgomery

1

0.3

337

82.2

27

6.7

9

2.8

33

8.3

407

Lucas

0

0

253

86.5

18

6.4

11

3.8

9

3.2

291

Stark

1

0.3

260

83.7

25

8.1

9

3.1

16

5

311

Summit

1

0.3

304

84.4

24

6.8

14

3.9

17

4.8

360

Ohio

3

0.02

6,630

83.2

555

6.9

269

3.4

506

5.5

7963

1

Data Source: Cancer Incidence and Mortality among Ohio Residences, 2003-2007. Ohio Cancer Incidence Surveillance System, Ohio Department of Health,
August 2010.

In situ is an early form of cancer that is defined by the absence of tumor cells into the surrounding tissue. A localized stage
cancer diagnosis is considered an early stage diagnosis in which the invasive cancer is confined to the organ of origin. Regional stage
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Table 8. Average Annual Number and Percent of Prostate Cancer Cases, by County of Residence and Stage at Diagnosis, 200320071

is considered a late stage diagnosis and corresponds to a direct extension to neighboring organs or tissues or the involvement of the
regional lymph nodes. Distant stage is a late stage diagnosis that is correlated with a higher cancer mortality rate because the cancer
has metastasized to parts of the body.
Montgomery County had the highest total prostate cancer cases compared to the other counties. Montgomery County had the
lowest percent of localized (82.2%) and distant stage (2.8%) at diagnosis in comparison to Ohio and the other counties. Additionally,
Montgomery County had the second highest percent of regional stage (6.7%) at diagnosis in comparison to the other metropolitan
45

counties. Montgomery County was on par with in situ (0.3%) at diagnosis compared to the other counties.
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Figure 2. Staged Prostate Cancer Trends, Montgomery County, Ohio, 2000-2009 a

90.0
80.0

Percent

70.0
60.0

In situ

50.0

Localized

40.0

Regional

30.0

Distant
Unstaged

20.0
10.0
0.0
2000
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2002

2003

2004

2005

2006

2007

2008

2009

Year
a

Data Source: Ohio Cancer Incidence Surveillance System (OCISS), 2000-2009

In Montgomery County, from 2000 to 2009, the localized (early) stage of prostate cancer
diagnosis is ranked the highest among all stages followed by in situ (early), regional (late),
distant (late), and unknown (Figure 2). Comparing prostate cancer stage according to the spread
or variability of data, localized stage has the most variability followed by unstaged/unknown,
regional, distant and in situ.
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Figure 3. Trends in the Proportion of Cases (%) by All Stages at Diagnosis in Montgomery
County, Ohio, 2000-2009 a

80.0
70.0
60.0

Percent

50.0
All Stages
Caucasian

40.0
30.0

All Stages
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20.0
All Stages
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0.0
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2003
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2009

Year
a

Data Source: Ohio Cancer Incidence Surveillance System (OCISS), 2000-2009

Figure 3 shows the distribution of all stages at diagnosis of prostate cancer by race and
year of diagnosis from 2000 to 2009. During this time period, compared to African American
men and men of other/unknown races, a larger proportion of Caucasian men were diagnosed
with prostate cancer. This is because Caucasians make up a larger portion of the population.
However, from 2007 to 2008, Caucasian men diagnosed with prostate cancer decreased by four
percentage points, but then increased by six percentage points from 2008 to 2009. The trend was
reversed for African American men during the 2007 to 2008 period; during that period, African
American men diagnosed with prostate cancer increased by seven percentage points but then
decreased by seven percentage points between 2008 and 2009. From 2000 to 2009 men of other
and unknown races remained relatively constant.

US
Stage at
diagnosis
In situ
Localized
Regional
Distant
Unstaged
Montgomery
County
Stage at
diagnosis In situ
Localized
Regional
Distant
Unstaged
Montgomery
County
Stage at
diagnosis In situ
Localized
Regional
Distant
Unstaged

2001-2007
Rate
0.0
82.0
11.0
4.0
3.0

2000
Rate
0
70.9
5.1
4.9
16.3

n
0
272
19
18
60

2001
Rate
0
70.9
8
4.6
16.5

n
0
249
28
16
58

2002
Rate
0
78.9
6.8
1.8
12.5

2003
n
0
302
26
7
48

Rate
0.3
77.6
6.6
2.8
12.7

n
1
281
24
10
46

2004
Rate
0
80.4
7.9
3.9
7.9

n
0
307
30
15
30

2005
Rate
0
85.8
7.4
1.3
5.6

n
0
337
29
5
22

2006
Rate
0
87.4
4.9
2.9
4.9

n
0
396
22
13
22

2007
Rate
0
79.7
6.8
3.1
10.5

n
0
366
31
14
48

2008
Rate
0
78.2
6.0
2.9
12.9

n
0
327
25
12
54

2009
Rate
0
78.3
8.3
4.0
9.4

n
0
293
31
15
35
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Table 9. Incidence rates for prostate cancer, by stage at diagnosisab

a

2000-2002

2003-2007

2008-2009

Rate
0.0
73.6
6.6
3.8
15.1

Rate
0.1
82.2
6.7
2.8
8.3

Rate
0.0
78.3
7.1
3.4
11.1

New cases diagnosed per 100,000 Males
Data Sources: Ohio Cancer Incidence Surveillance System (OCISS), 2000-2009, Ohio Department
of Health; National Cancer Institute (US data)
c
Incidence calculated using 2000 Census Data
b

Rates for localized prostate cancer increased substantially from 2000 to 2006, but decreased slightly
from 2007 to 2009
Rates for regional prostate cancer increased slightly from 2000 to 2001, but decreased slightly from
2001 to 2003. From 2003 to 2009 the rates fluctuated with an overall increasing trend.
Rates for distant prostate cancer decreased from 2000 to 2002, increased from 2003 to 2004, and
fluctuated slightly from 2005 to 2009.
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Rates of unstaged prostate cancer for Montgomery County is higher than US.
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Table 10: Percent distribution by grade (Cell Differentiation), Age group and Race in
Montgomery County, 2000-20091
Grade

Caucasian

African
American

Other/Unknown

Age <65
Well differentiated; Grade 1
Moderately differentiated; Grade 2
Poorly differentiated; Grade 3
Undifferentiated; anaplastic; Grade 4
Unknown

0.7
20.2
11.8
0.1
1.4

2.0
21.9
13.8
0.9
1.8

0.4
18.6
5.3
0.0
4.5

Age ≥ 65
Well differentiated; Grade 1
Moderately differentiated; Grade 2
Poorly differentiated; Grade 3
Undifferentiated; anaplastic; Grade 4
Unknown

1.5
32.6
23.4
0.5
7.9

2.3
26.8
20.5
0.9
9.2

0.8
31.4
24.6
0.8
13.6

a

Data Source: Ohio Cancer Incidence Surveillance System (OCISS), 2000-2009

Table 10 shows the distribution of prostate cancer in Montgomery County by grade, age
group and race. Grade 1 represents the least atypical and aggressive form of cancer with well
differentiated cells. Grade 2 represents prostate cells that have maintained their normal
characteristics (moderate differentiation). Grade 3 represents poorly differentiated cells or an
atypical and aggressive form of prostate cancer. Grade 4 represents undifferentiated cell, which
is also the most aggressive form of prostate cancer.
From 2000 to 2009, the grade distribution did not differ noticeably by age group or race.
The majority of males living in Montgomery County during this time period were diagnosed
with moderately differentiated (grade 2) and poorly differentiated (grade 3) prostate cancer,
despite age group or race.
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Figure 4. Invasive Prostate Cancer Incidence Trend of Montgomery and other
metropolitan counties of Ohio, 1998-2007a
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Data Source: Ohio Department of Health, Ohio Public Health Information,
http://publicapps.odh.ohio.gov/pwh/pwhmain.aspx

Overall, the incidence trend for prostate cancer in Montgomery County from 1998 to
2007 appears generally consistent. However, from 2004 to 2007, the invasive prostate cancer
incidence trend appears to be increasing. Additionally, from 1998 to 2004, the trend for
Montgomery County was lower than the Ohio, Summit, and Lucas County. Ohio data seems
more stable compared to the county data, which may be due to the number of cases in the state
during that time period.
Notes:
Invasive Prostate Cancer is a malignant tumor that originates in the prostate, and then
spreads into nearby healthy tissue. It may require a more insistent treatment approach
than in situ prostate cancer.
Malignant tumors pertain to a tumor that can potentially invade and destroy neighboring
tissue and metastasize to other regions of the body.
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Figure 5. Prostate Cancer Mortality Trend of Montgomery and other metropolitan
counties in Ohio, 2000-2008a

12.0
10.0
Montgomery

Percent

8.0

Lucas

6.0

Stark

4.0

Summit
Ohio

2.0
0.0
2000-2002

2003-2005

2006-2008

Year
a

Data Source: Ohio Department of Health, Ohio Public Health Information,
http://publicapps.odh.ohio.gov/pwh/pwhmain.aspx

Prostate cancer mortality rate in Montgomery County from 2006 to 2008 decreased by
2.5 percentage points from 2000 to 2002. During 2006 to 2008, Montgomery County had the
third lowest rate of prostate cancer mortality compared to Ohio and the other metropolitan
counties in the State.
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Figure 6. Average Annual Age-adjusted Incidence Rates of Invasive Prostate Cancer, by
Census Tract, in Montgomery County, 1996-20051-4

1

Source: Ohio Cancer Incidence Surveillance System, Ohio Department of Health, 2008.
Rates are per 100,000 and were calculated using vintage 2006 intercensal estimates for July 1, 1996-1999 and
postcensal estimated for July 1, 2000-2005, (U.S. Census Bureau, 2007). Rates are direct age adjusted to the U.S.
2000 standard population.
3
NOTE: Large census tracts may appear to have higher rates and risks due to their size -interpret with caution.
4
Cut points for rate quartiles were derived from the distribution for the State of Ohio.
*Rates may be unstable and are not presented when the count for 1996-2005 is less than five (i.e., average annual
count is <1). A number (less than 1%) of unusually high outlying incidence rates are also not presented.
2

The incidence rate of prostate cancer appears to be higher in larger census tracts.
However, as referenced above, they appear to have higher rates because of their size. Therefore,
the higher incidence rates for prostate cancer may not have a particular trend in a specific region.
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Descriptive Analysis of Men with Prostate Cancer in Montgomery County
Table 11. Characteristics of Montgomery County Men with Prostate Cancer 2000-20091
Total
Early Stage
Late Stage
Diagnosis
Diagnosis
Category
Total

n
3971

%
100

n
3130

%
100

n
399

%
100

Demographics
Race/Ethnicity
Caucasian
African American
Other/Unknown

2805
883
283

70.6
22.2
7.2

2227
699
204

71.2
22.3
6.5

294
91
14

73.7
22.8
3.5

Age at Diagnosis
<40
40-49
50-59
60-69
70-79
80-89
90+

4
88
686
1410
1259
464
60

0.1
2.2
17.3
35.5
31.7
11.7
1.5

4
64
561
1179
1025
279
18

0.1
2.0
17.9
37.7
32.7
8.9
0.6

0
19
95
140
86
53
6

0.0
4.8
23.8
35.1
21.6
13.3
1.5

City of Diagnosis
Beavercreek
Brookville
Carlisle
Centerville
Clayton
Dayton
Englewood
Farmerville
Germantown
Huber Heights
Kettering
Miamisburg
Middletown
Moraine
New Lebanon
Jefferson Township
Oakwood
Perry Township
Phillipsburg
Riverside

13
109
3
267
39
2063
130
20
57
222
345
194
1
30
43
1
1
1
4
4

0.3
2.7
0.1
6.7
1.0
52.0
3.3
0.5
1.4
5.6
8.7
4.9
0.0
0.8
1.1
0.0
0.0
0.0
0.1
0.1

9
89
3
209
33
1626
114
14
45
182
262
148
1
23
35
0
0
0
4
3

0.3
2.8
0.1
6.7
1.1
52.0
3.6
0.4
1.4
5.8
8.4
4.7
0.0
0.7
1.1
0.0
0.0
0.0
0.1
0.1

1
12
0
26
5
208
10
4
3
29
34
19
0
2
6
0
0
0
0
1

0.3
3.0
0.0
6.5
1.3
52.1
2.5
1.0
0.8
7.3
8.5
4.8
0.0
0.5
1.5
0.0
0.0
0.0
0.0
0.3
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Springboro
Tipp City
Trotwood
Union
Vandalia
Washington Twp.
West Alexandria
West Carrollton
Xenia

2
1
134
36
103
43
3
99
1

0.1
0.0
3.4
0.9
2.6
1.1
0.1
2.5
0.0

Early Stage
Diagnosis
1
0.0
1
0.0
103
3.3
33
1.1
82
2.6
26
0.8
3
0.1
78
2.5
1
0.0

Late Stage
Diagnosis
0
0.0
0
0.0
14
3.5
3
0.8
10
2.5
3
0.8
0
0.0
9
2.3
0
0.0

Marital Status
Single
Married
Divorce/Separated
Widowed
Unknown

260
2542
300
302
447

6.5
64.0
7.6
7.6
11.3

195
2126
230
191
309

6.4
69.7
7.5
6.3
10.1

42
256
34
39
19

10.8
65.6
8.7
10.0
4.9

Primary Payer
Not Insured
Private Insurance
Medicaid
Medicare
Military
Insured NOS
Unknown

54
1028
50
1921
62
308
369

1.4
25.9
1.3
48.4
1.6
7.8
9.3

30
428
22
792
2
140
797

1.4
19.4
1.0
35.8
0.1
6.3
36.0

1
61
3
104
0
16
19

0.5
29.9
1.5
51.0
0.0
7.8
9.3

Zip Code of Diagnosis
45005
45066
45237
45042
45309
45315
45322
45325
45327
45342
45343
45345
45354
45371
45377

3
2
1
1
110
39
166
20
57
192
2
43
4
1
105

0.1
0.1
0.0
0.0
2.8
1.0
4.2
0.5
1.4
4.8
0.1
1.1
0.1
0.0
2.6

3
1
1
1
89
33
147
14
45
146
2
35
4
1
82

0.1
0.0
0.0
0.0
2.8
1.1
4.7
0.4
1.4
4.7
0.1
1.1
0.1
0.0
2.6

0
0
0
0
12
5
13
4
3
19
0
6
0
0
10

0.0
0.0
0.0
0.0
3.0
1.3
3.3
1.0
0.8
4.8
0.0
1.5
0.0
0.0
2.5
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45381
45401
45402
45403
45404
45405
45406
45407
45408
45409
45410
45413
45414
45415
45416
45417
45418
45419
45420
45422
45424
45426
45427
45428
45429
45431
45432
45434
45437
45439
45440
45449
45458
45459
45470
45475
Other
Prostate Cancer Survival
Yes
No
1

55

3
1
89
62
48
128
187
1
17
39
63
3
167
122
56
324
9
104
119
3
332
161
26
3
255
66
50
2
2
67
103
127
191
292
1
1

0.1
0.0
2.2
1.6
1.2
3.2
4.7
0.0
0.4
1.0
1.6
0.1
4.2
3.1
1.4
8.2
0.2
2.6
3.0
0.1
8.4
4.1
0.7
0.1
6.4
1.7
1.3
0.1
0.1
1.7
2.6
3.2
4.8
7.4
0.0
0.0

Early Stage
Diagnosis
3
0.1
1
0.0
60
1.9
50
1.6
37
1.2
100
3.2
146
4.7
1
0.0
10
0.3
31
1.0
50
1.6
1
0.0
140
4.5
104
3.3
42
1.3
260
8.3
3
0.1
80
2.6
91
2.9
0
0.0
277
8.9
128
4.1
12
0.4
1
0.0
199
6.4
49
1.6
45
1.4
1
0.0
1
0.0
53
1.7
78
2.5
96
3.1
137
4.4
238
7.6
0
0.0
0
0.0

3306
665

83.3
16.7

2797
333

89.4
10.6

Data Sources: Ohio Cancer Incidence Surveillance System (OCISS), 2000-2009, ODH

Late Stage
Diagnosis
0
0.0
0
0.0
13
3.3
5
1.3
3
0.8
13
3.3
21
5.3
0
0.0
3
0.8
6
1.5
5
1.3
0
0.0
13
3.3
11
2.8
6
1.5
31
7.8
1
0.3
13
3.3
9
2.3
0
0.0
40
10.0
15
3.8
2
0.5
0
0.0
28
7.0
7
1.8
3
0.8
0
0.0
1
0.3
3
0.8
11
2.8
13
3.3
26
6.5
25
6.3
0
0.0
0
0.0

298
101

74.7
25.3
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Those diagnosed with prostate cancer in Montgomery County were primarily men
between the age of 60 to 79, Caucasian men, married men, and men who used Medicare as their
primary source of healthcare. The men within these groups were more likely to be diagnosed
with early stage prostate cancer.
Additionally, men living in the City of Dayton and within the 45424 zip code had the
highest percentage of prostate cancer diagnosis, 52% and 8.4% respectively, compared to the
other cities and zip codes in Montgomery County. However, men living within those regions
were more likely to be diagnosed with early stage prostate cancer. Men who used Medicare as
their primary source of healthcare had the highest percentage of prostate cancer diagnosis of all
primary payers. Thirty-six percent of men on Medicare were diagnosed with early stage prostate
cancer and fifty-one percent were diagnosed with late stage prostate cancer.
Lastly, men were more likely to survive with early or late stage diagnosis during that time
period than men who passed away from the disease. Overall, men living in the county were more
likely to be diagnosed with early stage prostate cancer compare to late stage diagnosis.
Table 12. Evaluating health differences by Race1
Race

Living

%

Deceased

%

Caucasian

2318

70.1

487

73.2

African American

734

22.2

149

22.4

Other/Unknown

254

7.7

29

4.4

Total

3306

100.0

665

100.0

1

Data Source: Ohio Department of Health, Ohio Cancer Incidence Surveillance System, 2000-2009.

There is a difference among Caucasian men diagnosed with prostate cancer, when
compared to African American men and men of other or unknown races. During the ten year
time period, 70.1 percent of all prostate cancer cases were Caucasian men and 73.2% of all who
died from prostate cancer were Caucasian men.
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Discussion
Primary Prevention Factors
The primary prostate cancer risk factors assessed included age, race, and socioeconomic
status. Prostate cancer related health factors such as smoking, alcohol abuse, tobacco use,
overweight/obesity, physical inactivity, fruit and vegetable consumption, and PSA testing were
also assessed.
The 2000 to 2009 Montgomery County population was comprised of more women than
men and a greater amount of Caucasians than African Americans. Examining the socioeconomic
status for Montgomery County, the median income was lower than the state and national
average. The median earnings for male full time workers were slightly lower than the national
average and Ohio. Additionally, the percentage of families living below the poverty level was
greater than Ohio and the US.
During that period there were less people with higher education when compared to the
state and national average. People living in the county were less likely to have insurance
compared to the state and the US. Men without health insurance are less likely to receive proper
care, which increases their risk of developing and dying from prostate cancer.
Socioeconomic indicators can play a vital role in onset of prostate cancer because men
may not have the means to pay for proper treatment and preventative screenings. Montgomery
County had the third highest rate of prostate cancer when compared to the other counties, Ohio,
and the US.
In comparison to the other metropolitan counties, Ohio, and the US in 2007, Montgomery
County showed a slight variation with regards to the percent of men over forty who received a
PSA test within the last two years, the percent of people who consume less than five servings of
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fruits and vegetables, and the percent of heavy drinkers. Conversely, Montgomery County had
the lowest rate of physical inactivity and had the highest rate of overweight people, but had the
lowest rate of individuals who were classified as obese. Men who engage in physical activity are
less likely to become overweight or obese and are less likely to develop prostate cancer (National
Institutes of Health, 2009). Interventions focusing on exercise such as educational programs can
assist on reducing the number of prostate cases in Montgomery County (American Cancer
Society, 2012).
Men over the age of thirty-five living in Montgomery County during the ten year time
period were unlikely to consume more than five servings of fruits and vegetables per day. A diet
rich in fat may be associated with an increased risk of prostate cancer (Stein & Colditz, 2004).
Fruits can have protective or preventative effects against prostate cancer. Some fruits and
vegetables contain anti-oxidants which serve as protective agents that shield prostate cells from
oxidation. They also have a variety of vitamins and minerals which may protect some men from
developing prostate cancer.
Montgomery County was above the state and national average for the percent of men
over the age of 40 who had a PSA test within the last two years. Since PSA testing is a screening
tool and protective factor used to diagnose prostate cancer, above national and state average may
possibly explain the reasoning behind why prostate cancer incidences and mortality ranks third
and fifth respectively in Montgomery County. Furthermore, men over the age of 65 were more
likely to receive a PSA test compared to their younger counterpart. African American men living
in Montgomery County were slightly more likely to receive a PSA test than Caucasian men.
Furthermore, male college graduates and men with an annual income between $25,000
and $49,000 per year were more likely to receive a PSA examination; this may be due to their
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overall awareness of the disease and their means to pay for treatment or receive screening for the
disease. More than half of the men age 40 and older living in Montgomery County received a
PSA exam within the last two years, which is above the state and national average.
Early Detection Factors
Secondary risk factors assessed for prostate cancer consisted of prostate cancer incidence,
mortality, grade, and the stage of diagnosis. Additionally, data was plotted by year to examine
the trends in prostate cancer incidence, mortality, and staging.
Montgomery County had the second highest incidence rate for all cancer sites and the
second lowest mortality rate for all cancer sites compared to the other counties, Ohio, and the
US. Additionally, it had the third highest incidence rate for prostate cancer and the lowest
mortality rate for prostate cancer. A low mortality rate may be associated with access to
healthcare, medical insurance, and proper treatment and screenings (National Institutes of
Health, 2008). In comparison to the other counties, Ohio, and the US, Montgomery County had
the lowest percentage of men diagnosed with late stage prostate cancer; the reason for this may
be due to the median annual earning for men living in the county, the number of men that receive
PSA testing, the low percent of uninsured men, the low number of men classified as obese, and
the percent of men that engage in physical activity.
In Montgomery County the prostate cancer incidence rate tends to affects men beyond
the age of 40, specifically men between the age of 60-79, which is relatively consistent globally
(American Cancer Society, 2011). Among African American and Caucasian men the incidence
rate peaks between the 60 to 69 age group. However, men of other or unknown races rate peaked
between the 70 to79 age group. Beyond the age group of 60 to 69 for Caucasian and African
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American men and 70 to 79 for men of other/unknown races, the incidence begins to decrease.
This may be due to the amount of data collected on men beyond this age group.
Prostate cancer by stage at diagnosis from 2003 to 2007 showed that Montgomery
County had the highest rate of unstaged/unknown cases compared to the other counties and
Ohio. From 2000 to 2009 Montgomery County had a large percent of cases diagnosed at the
localized stage. However, in comparison to the other counties and Ohio from 2003 to 2007
Montgomery County ranked last at this stage of diagnosis. In comparison to the US from 2001 to
2007, Montgomery County was below average. Localized stage is considered an early stage
diagnosis, and is correlated with lower mortality rates. The reason for this may be due to
socioeconomic factors such as the percent of insured men, and the annual earning of men living
in the county. Additionally, the number of men that receive proper testing and screenings, and
the percent of men who are insured may explain the reasoning behind early stage diagnosis in
Montgomery County. During that time period, there has been much variability with regional and
distant stage of diagnosis. Despite, the large percent of localized stage of diagnosis and the
variability in distant and regional stage at diagnosis, Montgomery County stage at diagnosis is
lower than the national average.
The trend for all stages of prostate cancer at diagnosis from 2000 to 2009 remained
generally consistent for all races. However, a larger rate of Caucasian men were diagnosed with
prostate cancer for each year during that time period compared to African American men and
men of other or unknown races. This is because Caucasian men make up a larger portion of the
population. Specifically, from 2007 to 2008, the rate of Caucasian men diagnosed with all stages
of prostate cancer decreased slightly, while the rate for African American men diagnosed at all
stages of prostate cancer increased slightly. The opposite can be seen from 2008 to 2009. The
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rate for African American men increased, while the rate for Caucasian men decreased. This
difference may be due to the population asymmetry between African American, and Caucasian
men living in the county during that time period.
When comparing prostate cancer by grade, age and race, there was not a significant
difference between men under the age of 65 and those over the age of 65 regardless of race.
Grade or cell differentiation describes how atypical or aggressive prostate cancer cells may
appear. It is beneficial in predicting how a patient may respond to treatment and prognosis.
The invasive prostate cancer trend for Montgomery County from 1998 to 2007 was
generally consistent, maintaining an average of 147.4 cases per 100,000 people. This consistency
is possibly due to men receiving preventative testing and screenings for early diagnosis. The
mortality trend for Montgomery County from 2003 to 2008 increased slightly, but this is
possibly due to misclassification of unstaged and unknown cases throughout the county.
Descriptive Analysis of Men with Prostate Cancer in Montgomery County
This analysis of men living in Montgomery County with prostate cancer was described
using data from the OCISS (Ohio Department of Health, 2012).
Men living in Montgomery County diagnosed with prostate cancer mainly included:
Caucasian men; men in the 60 to 79 age group; men living in Dayton, Ohio and in the 45424 zip
code; married men; and men with Medicare as their primary insurance. The result of the
descriptive analysis is representative of population living in Montgomery County since 76
percent of the population is Caucasian and 34 percent is age 50 and older.
Caucasian and African American men living in the county were more likely to be
diagnosed with late stage prostate cancer compared to men of other or unknown races who were
more likely to be diagnosed with early stage prostate cancer. Additionally, African American and
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Caucasian men were equally likely to be diagnosed with early or late stage diagnosis. This does
not correspond with the literature review that African American men are less likely to be
diagnosed with prostate cancer at a localized stage and are more likely to be diagnosed at a
distant stage when the cancer has spread to other regions of the body (Jemal et al., 2011).
Men in the 60 to 79 age group, and married men, were more likely to be diagnosed with
early stage prostate cancer. This confirms the literature review that age is a strong risk factor for
prostate cancer; men over the age of fifty are more likely to be diagnosed with prostate cancer
(Delongchamps, Singh, & Hass, 2006). Interestingly, men living in the City of Dayton were
more likely to be diagnosed with early stage prostate cancer; while men living in the 45424 zip
code were more likely to be diagnosed with late stage prostate cancer. Primary payer at diagnosis
showed that men with private insurance or on Medicare were more likely to be diagnosed with
late stage prostate cancer. This correspond with the literature review that insurance type
influence the type treatment received (Sadetsky et al., 2008).
Men living in the county were more likely to survive when diagnosed with early stage
prostate cancer compared to those diagnosed at the late stage. This corresponds with the
literature review that there is a 100% survival rate among men of all races diagnosed with
localized prostate cancer within for the first five years of diagnosis (Fedewa et al., 2010).
Considering that from 2000 to 2009 a large percentage of men living in the county were
diagnosed localized prostate cancer.
When examining the health disparity by race, it was determined that there was a disparity
among Caucasian men diagnosed with the disease. During the ten year time period, 70.1 percent
of all prostate cancer cases were Caucasian men and 73.2% of all who died from prostate cancer
were Caucasian men.
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Limitations
The lack of data available from the OCISS for men of other and unknown races serves as
a limitation to the study. Additionally, the estimated data for the percent of men who consume
less than 5 servings of fruits or vegetables per day in Montgomery County may serve as a
limitation of this study because the percentages can be higher or lower than the estimated
percentages reported. The percent of men 40 and older who reported having had a prostate
specific antigen test living in Montgomery County may also serve as a limitation of this study
because there may be some variation with the estimated reported percentages. Lastly, the low
number of cases available for unstaged/unknown cases may serve as a limitation of this study.
Accurate cancer stage diagnosis is essential because treatment is directly associated to cancer
stage. Therefore, inaccurate staging could lead to improper treatment, and may reduce a patient
chance of survival.
Conclusion
Men living in Montgomery County are likely to be diagnosed with early stage prostate
cancer. The incidence and mortality rate of prostate cancer in Montgomery County is highly
associated with men beyond the age of 40 years old. The incidence and mortality disparity
between African American men, Caucasian men, and men of other or unknown races is unlikely
due to race, but more likely due to treatment, screening, diets, access to care, the quality of care
received, and the presence of co-morbid conditions.
This study demonstrated that disparities exist in Montgomery County with regards to
prostate cancer incidence and mortality, race, age, survival, primary payer, city, and zip code.
However, more data is needed to determine a causal relationship between these variables.
Measures can be taken to reduce the risk of developing prostate cancer such as, maintaining a
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healthy diet, increasing fruits and vegetables intake, maintaining a healthy weight, and increasing
physical activity. Measures should be implemented to decrease prostate cancer health disparities
through community-based participatory education, training, and research among racial/ethnic
minorities and underserved populations in Montgomery County.
Prostate cancer has multiple modifiable and non-modifiable risk factors ranging from
lifestyle to hormonal factors. Understanding the diversity of prostate cancer may lead to more
studies focusing on a personalized approach to treatment and screening. Identifying markers to
monitor, similar to high cholesterol as a predictor for heart disease, may give some indication as
to those at risk of developing the disease. Diet and lifestyle modification can be a daunting task,
but markers such as these can act as an incentive for people to modify their behavior.
Lastly, primary prevention programs can be used to educate men on the benefits of
exercise, maintaining a healthy weight, fruit and vegetable consumptions, and receiving proper
screening. Real progress will be achieved when future studies address the causes of prostate
cancer and implement early treatment and screening plans to better asses and manage
individuals, especially those who are at higher risk of developing the prostate cancer.
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Appendix C – List of Public Health Competencies Met
Domain #1: Analytic/Assessment
Identify the health status of populations and their related determinants of health and illness (e.g., factors
contributing to health promotion and disease prevention, the quality, availability and use of health services)
Describe the characteristics of a population-based health problem (e.g., equity, social determinants,
environment)
Use variables that measure public health conditions
Use methods and instruments for collecting valid and reliable quantitative and qualitative data
Identify sources of public health data and information
Recognize the integrity and comparability of data
Identify gaps in data sources
Adhere to ethical principles in the collection, maintenance, use, and dissemination of data and information
Describe the public health applications of quantitative and qualitative data
Collect quantitative and qualitative community data (e.g., risks and benefits to the community, health and
resource needs)
Use information technology to collect, store, and retrieve data

Domain #2: Policy Development and Program Planning
Gather information relevant to specific public health policy issues
Explain the expected outcomes of policy options (e.g., health, fiscal, administrative, legal, ethical, social,
political)
Identify mechanisms to monitor and evaluate programs for their effectiveness and quality
Demonstrate the use of public health informatics practices and procedures (e.g., use of information systems
infrastructure to improve health outcomes)

Domain #3: Communication
Communicate in writing and orally, in person, and through electronic means, with linguistic and cultural
proficiency
Convey public health information using a variety of approaches (e.g., social networks, media, blogs)
Participate in the development of demographic, statistical, programmatic and scientific presentations

Domain #4: Cultural Competency
Describe the dynamic forces that contribute to cultural diversity

Domain #5: Community Dimensions of Practice
Recognize community linkages and relationships among multiple factors (or determinants) affecting health
(e.g., The Socio-Ecological Model)
Identify community assets and resources

Domain #6:Public Health Sciences
Describes the scientific foundation of the field of public health
Relate public health science skills to the Core Public Health Functions and Ten Essential Services of Public
Health
Identify the basic public health sciences (including, but not limited to biostatistics, epidemiology, environmental
health sciences, health services administration, and social and behavioral health sciences)
Describe the scientific evidence related to a public health issue, concern, or, intervention
Retrieve scientific evidence from a variety of text and electronic sources
Discuss the limitations of research findings (e.g., limitations of data sources, importance of observations and
interrelationships)

Domain #7: Financial Planning and Management- N/A
Domain #8: Leadership and Systems Thinking
Identify internal and external problems that may affect the delivery of Essential Public Health Services
Use individual, team and organizational learning opportunities for personal and professional development
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